Bicycle Therapeutics BCYC Ratios (2018-2026)

NASDAQ BCYC
$4.30 +0.06 (+1.42%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Bicycle Therapeutics Quarterly Ratios

Periods 34 quarters
Latest Jun 2026

Bicycle Therapeutics reported a net margin of -8,002.07% for the quarter ended Jun 2026. These financial ratios cover 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
-348.33%-1,240.56%-724.95%-324.70%-940.30%-386.10%-810.50%-378.35%-889.87%-985.78%-137.80%-424.07%-2,027.28%-1,584.41%-619.84%-2,711.75%-501.92%-53.25%-6,837.99%-7,987.76%
EBIT Margin
-329.89%-1,126.50%-709.40%-325.00%-978.91%-383.46%-853.82%-378.27%-949.12%-1,017.35%-162.40%-498.31%-2,385.87%-1,824.78%-703.66%-2,965.82%-558.64%-51.52%-7,382.41%-8,673.93%
EBITDA Margin
-329.89%-1,126.50%-709.40%-325.00%-978.91%-383.46%-853.82%-378.27%-949.12%-1,017.35%-162.40%-498.31%-2,385.87%-1,824.78%-703.66%-2,965.82%-558.64%-51.52%-7,382.41%-8,673.93%
Operating Margin
-329.89%-1,126.50%-709.40%-325.00%-978.91%-383.46%-853.82%-378.27%-949.12%-1,017.35%-162.40%-498.31%-2,385.87%-1,824.78%-703.66%-2,965.82%-558.64%-51.52%-7,382.41%-8,673.93%
Net Margin
-338.75%-1,127.31%-714.09%-319.38%-932.47%-356.88%-797.88%-373.81%-932.32%-921.01%-136.01%-425.30%-1,898.43%-1,398.44%-608.94%-2,703.84%-503.66%-42.03%-6,857.38%-8,002.07%
FCF Margin
497.32%-718.88%-807.15%-396.79%-291.28%-378.06%-990.81%296.74%-28.53%-887.99%-362.93%-481.22%-1,504.75%-263.32%-871.75%-2,509.73%-612.30%-41.54%-7,512.74%-7,928.62%
Efficiency
Assets AverageAssets Avg.
253.69M380.56M469.68M452.52M431.31M413.88M419.70M441.49M546.43M617.01M571.24M802.25M1,027.05M976.81M920.38M858.04M798.07M740.78M685.00M629.49M
Invested CapitalInvested Cap.
200.58M376.13M360.27M341.54M319.71M301.10M273.58M250.61M446.63M401.63M386.85M904.72M
Asset Utilization RatioAsset Util.
0.050.030.020.040.040.060.060.060.050.040.070.050.040.040.030.020.040.100.090.10
Leverage & Solvency
Interest Coverage RatioInterest Cover
-17.37-21.98-33.48-30.92-36.42-39.00-51.74-52.51-62.40-66.14-38.63-56.61-0.00M-0.00M-0.00M-0.00M-0.00M-433.47-0.00M-0.00M
Debt Ratio
0.110.060.070.070.070.070.070.070.050.050.060.03
Times Interest Earned
-17.37-21.98-33.48-30.92-36.42-39.00-51.74-52.51-62.40-66.14-38.63-56.61-0.00M-0.00M-0.00M-0.00M-0.00M-433.47-0.00M-0.00M
Valuation
Price to EarningsP/E
-72.52-139.78-65.94-25.91-33.99-40.90-22.55-24.81-17.07-15.62-39.96-35.08-30.74-18.65-9.67-6.10-9.08-24.37-5.32-5.88
Price to SalesP/S
245.670.00M470.8782.74316.92145.96179.9592.75159.10143.9154.35149.18583.64260.7558.89164.8345.7210.24364.65470.61
Price to BookP/B
6.237.285.502.233.334.533.624.802.052.072.981.601.881.220.790.720.870.810.580.58
Enterprise Value
804.99M2,082.60M1,410.14M322.24M601.98M886.90M587.20M716.62M279.42M240.74M604.55M435.06M670.97M87.34M-205.45M-240.14M-111.89M-136.99M-236.06M-214.09M
EV to EBIT
-56.32-115.55-51.50-11.80-20.23-27.53-14.05-16.62-5.50-4.44-19.06-9.33-10.51-1.292.932.771.715.543.603.92
EV to EBITDA
-56.32-115.55-51.50-11.80-20.23-27.53-14.05-16.62-5.50-4.44-19.06-9.33-10.51-1.292.932.771.715.543.603.92
Market Capitalization
1,064.51M2,521.28M1,817.54M695.04M963.45M1,226.05M881.02M1,057.06M851.51M767.17M1,061.55M1,396.43M1,561.83M966.86M587.53M481.31M536.43M491.12M323.44M296.01M
Price to FCFP/FCF
49.40-219.20-58.34-20.85-108.80-38.61-18.1631.26-557.64-16.21-14.98-31.00-38.79-99.02-6.76-6.57-7.47-24.65-4.85-5.94
EV to FCF
37.36-181.06-45.26-9.67-67.98-27.93-12.1021.19-182.99-5.09-8.53-9.66-16.66-8.952.363.281.566.883.544.29
EV to CFO
37.07-199.58-53.41-13.69-102.53-29.26-12.6521.02-272.61-5.09-8.53-9.75-16.84-9.302.383.301.577.083.584.32
Return Ratios
Return on Sales [ROS]ROS
-329.89%-1,126.50%-709.40%-325.00%-978.91%-383.46%-853.82%-378.27%-949.12%-1,017.35%-162.40%-498.31%-2,385.87%-1,824.78%-703.66%-2,965.82%-558.64%-51.52%-7,382.41%-8,673.93%
Return on Capital Employed [ROCE]ROCE
-28.93%-19.06%-17.73%-21.16%-26.29%-32.36%-35.74%-39.78%-35.23%-34.69%-34.47%-25.03%-20.24%-23.07%-28.79%-36.93%-39.79%-36.13%-38.10%-36.14%
Return on Invested Capital [ROIC]ROIC
-34.21%-22.19%-20.44%-24.23%-30.43%-38.70%-46.78%-57.28%-49.86%-44.34%-45.19%-28.23%
Return on Assets [ROA]ROA
-26.08%-17.82%-16.86%-19.48%-23.60%-28.93%-31.27%-33.30%-30.85%-29.36%-29.52%-20.67%-16.23%-17.89%-22.71%-28.92%-32.13%-23.05%-24.94%-22.60%